S124: PHOSPHOPROTEOMICS ACCURATELY PREDICTS RESPONSES TO MIDOSTAURIN PLUS CHEMOTHERAPY IN TWO INDEPENDENT COHORTS OF FLT3 MUTANT-POSITIVE ACUTE MYELOID LEUKAEMIA

• Arran Dokal,
• Weronika E. Borek,
• Luis Nobre,
• Salvatore Federico Pedicona,
• Bela Wrench,
• Paolo Gallipoli,
• Andrea Arruda,
• Amy E. Campbell,
• Nazrath Nawaz,
• Harriet R. Ferguson,
• David N. Perkins,
• Pedro Moreno-Cardoso,
• Andrew Thompson,
• Andrew J.K. Williamson,
• Mark D. Minden,
• John G. Gribben,
• David J. Britton,
• Pedro R. Cutillas

Affiliations

Arran Dokal

1 Kinomica Limited, Alderley Edge, United Kingdom

Weronika E. Borek

1 Kinomica Limited, Alderley Edge, United Kingdom

Luis Nobre

1 Kinomica Limited, Alderley Edge, United Kingdom

Salvatore Federico Pedicona

1 Kinomica Limited, Alderley Edge, United Kingdom

Bela Wrench

2 Barts Cancer Institute, United Kingdom

Paolo Gallipoli

2 Barts Cancer Institute, United Kingdom

Andrea Arruda

3 Princess Margaret Cancer Centre, Toronto, Canada

Amy E. Campbell

1 Kinomica Limited, Alderley Edge, United Kingdom

Nazrath Nawaz

1 Kinomica Limited, Alderley Edge, United Kingdom

Harriet R. Ferguson

1 Kinomica Limited, Alderley Edge, United Kingdom

David N. Perkins

1 Kinomica Limited, Alderley Edge, United Kingdom

Pedro Moreno-Cardoso

1 Kinomica Limited, Alderley Edge, United Kingdom

Andrew Thompson

1 Kinomica Limited, Alderley Edge, United Kingdom

Andrew J.K. Williamson

1 Kinomica Limited, Alderley Edge, United Kingdom

Mark D. Minden

3 Princess Margaret Cancer Centre, Toronto, Canada

John G. Gribben

2 Barts Cancer Institute, United Kingdom

David J. Britton

1 Kinomica Limited, Alderley Edge, United Kingdom

Pedro R. Cutillas

1 Kinomica Limited, Alderley Edge, United Kingdom